Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

5.9%

1 terminated out of 17 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed with results

Key Signals

3 with results80% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (3)
Early P 1 (2)
P 1 (6)
P 2 (1)
P 3 (1)

Trial Status

Recruiting6
Completed4
Not Yet Recruiting3
Enrolling By Invitation1
Withdrawn1
Terminated1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT07075185Phase 1Recruiting

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

NCT03306277Phase 3Completed

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1

NCT03311503Phase 1Recruiting

Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

NCT05044845CompletedPrimary

Needs Assessment of Knowledge, Beliefs, and Attitudes of Patients With Hemophilia B About Gene Therapy

NCT03520712Phase 1Terminated

Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5

NCT01166009Recruiting

CIBMTR Research Database

NCT04728841Not ApplicableRecruiting

Gene Therapy for Chinese Hemophilia A

NCT07024524Not ApplicableRecruiting

Perceptual Evaluation and Rehabilitation System Development for Congenital Hearing Loss

NCT07085195Early Phase 1Not Yet Recruiting

A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease

NCT05210803Enrolling By Invitation

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

NCT06963008Early Phase 1Not Yet Recruiting

A Prospective, Single-center, Open-label Clinical Study to Evaluate the Safety and Efficacy of Inhaled BMD003(CFTR mRNA) in Chinese Adult Patients With Cystic Fibrosis

NCT06948019Phase 1Not Yet Recruiting

Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47)

NCT03734588Phase 1Completed

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

NCT05991336Recruiting

Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy

NCT04358471Phase 2Withdrawn

Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)

NCT04286815Not ApplicableUnknownPrimary

Gene Therapy for X Linked Severe Combined Immunodeficiency

NCT01024998Phase 1Completed

Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)

Showing all 17 trials

Research Network

Activity Timeline